Skip to main content

Research Repository

Advanced Search

Association between allopurinol use and hip fracture in older patients

Basu, Ujani; Goodbrand, James; McMurdo, Marion E.T.; Donnan, Peter T.; McGilchrist, Mark; Frost, Helen; George, Jacob; Witham, Miles D.

Authors

Ujani Basu

James Goodbrand

Marion E.T. McMurdo

Peter T. Donnan

Mark McGilchrist

Helen Frost

Jacob George

Miles D. Witham



Abstract

Background Allopurinol reduces oxidative stress and interacts with purinergic signalling systems important in bone metabolism and muscle function. We assessed whether allopurinol use was associated with a reduced incidence of hip fracture in older people. Methods Analysis of prospective, routinely-collected health and social care data on patients undergoing health and social work assessment in a single geographical area over a 12year period. Exposure to allopurinol was derived from linked community prescribing data, and hospitalisation for hip fracture and comorbid disease was derived from linked hospitalisation data. Fine and Gray modelling was used to model time to hip fracture accounting for the competing risk of death, incorporating previous use of allopurinol, cumulative exposure to allopurinol as a time dependent variable, and covariate adjustments. Results 17,308 patients were alive at the time of first social work assessment without previous hip fracture; the mean age was 73years. 10,171 (59%) were female, and 1155 (8%) had at least one exposure to allopurinol. 618 (3.6%) sustained a hip fracture, and 4226 (24%) died during a mean follow-up of 7.2years. In fully-adjusted analyses, each year of allopurinol exposure conferred a hazard ratio of 1.01 (95% CI 0.99, 1.02; p=0.37) for hip fracture and 1.00 (0.99, 1.01; p=0.47) for death. Previous use of allopurinol conferred a hazard ratio of 0.76 (0.45, 1.26; p=0.28) for hip fracture and 1.13 (0.99, 1.29; p=0.07) for death. Conclusion Greater cumulative use of allopurinol was not associated with a reduced risk of hip fracture or death in this cohort.

Citation

Basu, U., Goodbrand, J., McMurdo, M. E., Donnan, P. T., McGilchrist, M., Frost, H., …Witham, M. D. (2016). Association between allopurinol use and hip fracture in older patients. Bone, 84, 189-193. https://doi.org/10.1016/j.bone.2016.01.003

Journal Article Type Article
Acceptance Date Jan 4, 2016
Online Publication Date Jan 6, 2016
Publication Date 2016-03
Deposit Date Oct 12, 2017
Journal Bone
Print ISSN 8756-3282
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 84
Pages 189-193
DOI https://doi.org/10.1016/j.bone.2016.01.003
Keywords Gout, fracture, risk factor
Public URL http://researchrepository.napier.ac.uk/Output/996832